INCY
Incyte Corporation$121.65-0.52 (-0.43%)Prev Close$122.19·MCap$24.62B·P/E17.18·Vol838.1K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
39
$60.36M
◆
Net Activity
Net Seller
$60.36M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Incyte Corporation (INCY) has been exclusively selling, with 0 insider purchases totaling $0.00 and 39 insider sales totaling $60.36M. The most recent insider transaction was by CAGNONI PABLO J (officer: President, Global Head of R&D), who sold $1.36M worth of shares on Aug 20, 2026. Incyte Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $24.62B.
INCY Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 10,801 | $125.56 | $1.36M | 183,200 |
| Aug 14, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 10,803 | $120.04 | $1.30M | 194,001 |
| Aug 7, 2026 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | 2,207 | $123.99 | $273.6K | 61,441 |
| Aug 7, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 10,640 | $122.69 | $1.31M | 204,804 |
| Aug 4, 2026 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | 47,954 | $119.58 | $5.73M | 88,679-35% |
| Aug 4, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 15,888 | $119.70 | $1.90M | 215,444 |
| Jul 20, 2026 | Issa Mohamed Khairie | officer: EVP, Head of U.S. Commercial | Sell | 1,093 | $115.01 | $125.7K | 63,940 |
| Jul 20, 2026 | Stein Steven H | officer: CMO & Head of Late-Stage Dev. | Sell | 1,877 | $114.73 | $215.3K | 21,118 |
| Jul 16, 2026 | Stein Steven H | officer: CMO & Head of Late-Stage Dev. | Sell | 28,237 | $113.05 | $3.19M | 26,083-52% |
| Jun 8, 2026 | Tray Thomas | officer: Principal Accounting Officer | Sell | 2,639 | $100.00 | $263.9K | 21,132 |
| May 28, 2026 | Tray Thomas | officer: Principal Accounting Officer | Sell | 2,051 | $97.35 | $199.7K | 21,132 |
| May 21, 2026 | Clancy Paul J | director | Sell | 15,000 | $94.93 | $1.42M | 23,741-39% |
| Apr 21, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 18,667 | $96.50 | $1.80M | 262,692 |
| Mar 19, 2026 | CAGNONI PABLO J | officer: President, R&D | Sell | 18,667 | $94.24 | $1.76M | 234,800 |
| Feb 19, 2026 | CAGNONI PABLO J | President, R&D | Sell | 18,668 | $100.91 | $1.88M | 0 |
| Feb 4, 2026 | Heeson Lee | EVP, Head of Incyte Intl | Sell | 111 | $102.67 | $11.4K | 0 |
| Feb 4, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 185 | $102.67 | $19.0K | 0 |
| Jan 21, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 429 | $102.62 | $44.0K | 0 |
| Jan 8, 2026 | Issa Mohamed Khairie | EVP, Head of US Oncology | Sell | 19,120 | $108.03 | $2.07M | 0 |
| Jan 7, 2026 | Stein Steven H | EVP & Chief Medical Officer | Sell | 15,634 | $101.70 | $1.59M | 0 |
| Jan 5, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 254 | $98.77 | $25.1K | 0 |
| Jan 5, 2026 | Stein Steven H | EVP & Chief Medical Officer | Sell | 13,292 | $98.77 | $1.31M | 0 |
| Dec 22, 2025 | Tray Thomas | Principal Accounting Officer | Sell | 3,374 | $99.69 | $336.4K | 0 |
| Dec 18, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 58,331 | $97.29 | $5.67M | 0 |
| Dec 12, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5,808 | $95.55 | $555.0K | 0 |
| Dec 10, 2025 | Hoppenot Herve | Director | Sell | 2,843 | $96.70 | $274.9K | 0 |
| Dec 3, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 326 | $102.04 | $33.3K | 0 |
| Dec 3, 2025 | Stein Steven H | EVP & Chief Medical Officer | Sell | 39,757 | $102.34 | $4.07M | 0 |
| Nov 25, 2025 | Tray Thomas | Principal Accounting Officer | Sell | 769 | $102.78 | $79.0K | 0 |
| Nov 19, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $104.36 | $29.0K | 0 |
| Nov 12, 2025 | Hoppenot Herve | Director | Sell | 187,500 | $105.46 | $19.77M | 0 |
| Nov 7, 2025 | Stein Steven H | EVP & Chief Medical Officer | Sell | 5,233 | $102.20 | $534.8K | 0 |
| Nov 6, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $101.36 | $60.6K | 0 |
| Nov 5, 2025 | Heeson Lee | EVP, Head of Incyte Intl | Sell | 3,074 | $94.02 | $289.0K | 0 |
| Oct 17, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $85.13 | $23.6K | 0 |
| Oct 6, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 7,230 | $86.04 | $622.0K | 0 |
| Oct 3, 2025 | Heeson Lee | EVP, Head of Incyte Intl | Sell | 463 | $86.70 | $40.1K | 0 |
| Oct 3, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1,569 | $86.70 | $136.0K | 0 |
| Sep 18, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $83.15 | $23.1K | 0 |
| Sep 4, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $84.97 | $50.8K | 0 |
| Aug 19, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $86.81 | $24.0K | 0 |
| Aug 6, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $75.77 | $45.3K | 0 |
| Jul 23, 2025 | Stein Steven H | EVP & Chief Medical Officer | Sell | 3,706 | $67.94 | $251.8K | 0 |
| Jul 17, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 4,818 | $69.38 | $334.3K | 0 |
| Jul 17, 2025 | Flannelly Barry P | EVP & General Manager US | Sell | 1,340 | $68.36 | $91.6K | 0 |
| Jul 17, 2025 | Iyengar Vijay K | EVP, GMAPPS | Sell | 983 | $68.36 | $67.2K | 0 |
| Jul 17, 2025 | Trotta Matteo | EVP, GM, Dermatology US | Sell | 182 | $68.25 | $12.4K | 0 |
| Jul 16, 2025 | CAGNONI PABLO J | President, R&D | Sell | 3,908 | $68.82 | $268.9K | 0 |
| Jul 16, 2025 | Flannelly Barry P | EVP & General Manager US | Sell | 3,255 | $69.33 | $225.7K | 0 |
| Jul 16, 2025 | Hoppenot Herve | Special Advisor to the CEO | Sell | 9,674 | $69.14 | $668.8K | 0 |
Showing 1–50 of 119
1 / 3
INCY Insider Buying Activity
The following table shows recent insider purchases of Incyte Corporation (INCY) stock reported via SEC Form 4 filings.
No insider buying activity found for INCY in the last 12 months.
INCY Insider Selling Activity
The following table shows recent insider sales of Incyte Corporation (INCY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 10,801 | $125.56 | $1.36M | 183,200 |
| Aug 14, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 10,803 | $120.04 | $1.30M | 194,001 |
| Aug 7, 2026 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | 2,207 | $123.99 | $273.6K | 61,441 |
| Aug 7, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 10,640 | $122.69 | $1.31M | 204,804 |
| Aug 4, 2026 | Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | 47,954 | $119.58 | $5.73M | 88,679-35% |
| Aug 4, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 15,888 | $119.70 | $1.90M | 215,444 |
| Jul 20, 2026 | Issa Mohamed Khairie | officer: EVP, Head of U.S. Commercial | Sell | 1,093 | $115.01 | $125.7K | 63,940 |
| Jul 20, 2026 | Stein Steven H | officer: CMO & Head of Late-Stage Dev. | Sell | 1,877 | $114.73 | $215.3K | 21,118 |
| Jul 16, 2026 | Stein Steven H | officer: CMO & Head of Late-Stage Dev. | Sell | 28,237 | $113.05 | $3.19M | 26,083-52% |
| Jun 8, 2026 | Tray Thomas | officer: Principal Accounting Officer | Sell | 2,639 | $100.00 | $263.9K | 21,132 |
| May 28, 2026 | Tray Thomas | officer: Principal Accounting Officer | Sell | 2,051 | $97.35 | $199.7K | 21,132 |
| May 21, 2026 | Clancy Paul J | director | Sell | 15,000 | $94.93 | $1.42M | 23,741-39% |
| Apr 21, 2026 | CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 18,667 | $96.50 | $1.80M | 262,692 |
| Mar 19, 2026 | CAGNONI PABLO J | officer: President, R&D | Sell | 18,667 | $94.24 | $1.76M | 234,800 |
| Feb 19, 2026 | CAGNONI PABLO J | President, R&D | Sell | 18,668 | $100.91 | $1.88M | 0 |
| Feb 4, 2026 | Heeson Lee | EVP, Head of Incyte Intl | Sell | 111 | $102.67 | $11.4K | 0 |
| Feb 4, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 185 | $102.67 | $19.0K | 0 |
| Jan 21, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 429 | $102.62 | $44.0K | 0 |
| Jan 8, 2026 | Issa Mohamed Khairie | EVP, Head of US Oncology | Sell | 19,120 | $108.03 | $2.07M | 0 |
| Jan 7, 2026 | Stein Steven H | EVP & Chief Medical Officer | Sell | 15,634 | $101.70 | $1.59M | 0 |
| Jan 5, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 254 | $98.77 | $25.1K | 0 |
| Jan 5, 2026 | Stein Steven H | EVP & Chief Medical Officer | Sell | 13,292 | $98.77 | $1.31M | 0 |
| Dec 22, 2025 | Tray Thomas | Principal Accounting Officer | Sell | 3,374 | $99.69 | $336.4K | 0 |
| Dec 18, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 58,331 | $97.29 | $5.67M | 0 |
| Dec 12, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 5,808 | $95.55 | $555.0K | 0 |
| Dec 10, 2025 | Hoppenot Herve | Director | Sell | 2,843 | $96.70 | $274.9K | 0 |
| Dec 3, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | Sell | 326 | $102.04 | $33.3K | 0 |
| Dec 3, 2025 | Stein Steven H | EVP & Chief Medical Officer | Sell | 39,757 | $102.34 | $4.07M | 0 |
| Nov 25, 2025 | Tray Thomas | Principal Accounting Officer | Sell | 769 | $102.78 | $79.0K | 0 |
| Nov 19, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $104.36 | $29.0K | 0 |
| Nov 12, 2025 | Hoppenot Herve | Director | Sell | 187,500 | $105.46 | $19.77M | 0 |
| Nov 7, 2025 | Stein Steven H | EVP & Chief Medical Officer | Sell | 5,233 | $102.20 | $534.8K | 0 |
| Nov 6, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $101.36 | $60.6K | 0 |
| Nov 5, 2025 | Heeson Lee | EVP, Head of Incyte Intl | Sell | 3,074 | $94.02 | $289.0K | 0 |
| Oct 17, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $85.13 | $23.6K | 0 |
| Oct 6, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 7,230 | $86.04 | $622.0K | 0 |
| Oct 3, 2025 | Heeson Lee | EVP, Head of Incyte Intl | Sell | 463 | $86.70 | $40.1K | 0 |
| Oct 3, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | Sell | 1,569 | $86.70 | $136.0K | 0 |
| Sep 18, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 278 | $83.15 | $23.1K | 0 |
| Sep 4, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $84.97 | $50.8K | 0 |
| Aug 19, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 277 | $86.81 | $24.0K | 0 |
| Aug 6, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 598 | $75.77 | $45.3K | 0 |
| Jul 23, 2025 | Stein Steven H | EVP & Chief Medical Officer | Sell | 3,706 | $67.94 | $251.8K | 0 |
| Jul 17, 2025 | Denton Sheila A. | EVP & General Counsel | Sell | 4,818 | $69.38 | $334.3K | 0 |
| Jul 17, 2025 | Flannelly Barry P | EVP & General Manager US | Sell | 1,340 | $68.36 | $91.6K | 0 |
| Jul 17, 2025 | Iyengar Vijay K | EVP, GMAPPS | Sell | 983 | $68.36 | $67.2K | 0 |
| Jul 17, 2025 | Trotta Matteo | EVP, GM, Dermatology US | Sell | 182 | $68.25 | $12.4K | 0 |
| Jul 16, 2025 | CAGNONI PABLO J | President, R&D | Sell | 3,908 | $68.82 | $268.9K | 0 |
| Jul 16, 2025 | Flannelly Barry P | EVP & General Manager US | Sell | 3,255 | $69.33 | $225.7K | 0 |
| Jul 16, 2025 | Hoppenot Herve | Special Advisor to the CEO | Sell | 9,674 | $69.14 | $668.8K | 0 |
INCY Insiders
Similar Stocks to INCY
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B
BBIO
BridgeBio Pharma, Inc.
$68.85-4.79%
$14.19B